Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.

Abstract: The invention relates to chemical entities of formula (I): and/or pharmaceutically acceptable derivative(s) thereof. The invention also relates to processes for the preparation of compounds of formula (I), pharmaceutical compositions containing compounds of formula (I) and to the use of compounds of formula (I) in medicine, particularly in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: A vehicle window opening/closing switch apparatus for opening/closing a plurality of windows provided on a vehicle is disclosed. The apparatus has a first switch and a second switch. An arbitrary window can be electrically selected from among the windows by manually displacing the first switch to at least the left and right. The second switch is incorporated in the first switch and is capable of electrically opening/closing the window selected by the first switch by a manual operation.

Abstract: A cable organization unit includes a housing. A tray is attached to the housing by at least one slide, and is movable between a first position and a second position relative to the housing. A hood is removably secured to the tray. A user may remove the hood from the tray to access adapters attached to a bulkhead on the tray. The tray may include a latch for securing the tray to the housing in the first position, and the hood may be removed from the tray while the tray is in the first or second positions. A retainer is optionally attached to the housing. The retainer includes an adjustable opening which may be reduced in size such that edges of the opening frictionally engage and hold a jacket of a cable passing therethrough.

Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: A method, apparatus, and memory storing instruction that generate one or more playlists. In one aspect, a playlist is generated by calculating coincidences distances between pairs of items in a group and generating a playlist of plural of the items in the group responsive to the coincidence distances. In another aspect, two related playlists are generated, for example by using a same coincidence criteria for the playlists or by using mutual similarity criteria between the playlists.

Abstract: A home theater system includes construction, presentation, and commerce in, songs. Presentation includes at least one of: metadata about songs or sounds, a function capable of transitioning from one song to a next song, and user preferences; and can determine in what manner to transition from one song to a next song. Construction of songs includes either factors above, or at least one of: a function or a user extension capable of selecting a next song, and an element capable of determining whether the song is perceptually random. A user interface is capable of searching playlists and selecting them for presentation, representing each playlist with a substantially unique pictorial representation, distinguishing in presentation between those playlists licensed to the user and those that are not, and capable of substantially immediate purchase of playlist licenses either individually or in bulk and either automatically or with minimal intervention.

Abstract: Digital media recognition without substantial user interaction, using information from personal digital libraries, or about users. Digital media recognition ambiguities resolved using that information, including: a preponderance of entries in the user's personal library, including specific songs, authors, or genres; a similarity relationship between the user's personal library and the corpus of a collective library; demographic or specific information about the user; equality to a song already present; earlier results in resolving ambiguities; location of a mobile system in a designated region; location in a designated place within a house; existence of any parental controls; whether the imported digital entertainment information is being imported in bulk as part of a collection; whether, according to a selected similarity metric for digital entertainment information, the imported digital entertainment information would be “closer” to one or more elements of the user's personal library.

Abstract: The cell-based assays described in the present invention can be used to directly assess the sensitivity and specificity of the gene annotation reagent against its target, and to determine if a non-targeted gene participates in a pathway of interest or is functionally linked to another gene or protein. The combination of annotation reagents with such cell-based assays is useful for mapping genes (proteins) into cellular pathways on a genome-wide scale. Preferred assay embodiments include fluorescence or luminescence assays in intact (live or fixed) cells. Such fluorescence or luminescence assays include high-throughput or high-content assays for protein activity, subcellular localization, post-translational modifications, or interactions of proteins. Suitable assays may include protein-protein interaction assays; protein translocation assays; and post-translational modification assays.

Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.

Abstract: The invention relates to compounds of formula (I) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: A method of embedding information in digital content representing media streams. The method includes (1) selecting a set of locations within that digital content representing the media stream to embed information, (2) selecting a set of possible alterations to make at those locations, and (3) making a subset of the possible alterations. The set of locations and possible alterations is herein sometimes called a “watermark.” The subset of actual alterations that are made is herein sometimes called a “fingerprint.” The method determines a set of locations at which there are alternative versions of digital content representing the same media stream, such as one being the original and one being an alternative version of the same digital content, herein sometimes called the “original movie” and the “alt-movie,” or herein sometimes called the “original block” and the “alt-block” for a particular block in the digital content representing the media stream.

Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: The invention provides a method of recovering from de-synchronization attacks includes registering original and altered digital content using nonlinear transformations to iteratively attempt to provide better-approximated registration. Approximation occurs at more than one level of granularity, by selecting among a greater number of possible transformation functions at each step. Transformations and comparisons might be conducted directly on pixel values, on coefficients for a set of basis wavelets, or on some transformation of the original and altered digital content. A human operator might assist this process, such as by suggesting transformations or providing evaluation of the degree of registration. Upon resynchronization, embedded identifying information in the original digital content is recovered.

Abstract: Embedding fingerprinting or watermarking information includes delivering information in-band within digital content representing a media stream, so unauthorized distributors must choose between degrading the media stream, or leaving sufficient information detectable that unauthorized distribution can be detected. For fingerprinting, the method provides a relatively high degree of confidence of both detecting at least one colluding unauthorized distributor, and not falsely accusing any innocent party of being an unauthorized distributor. Embedding fingerprinting or watermarking information includes selecting a sequence of locations within digital content, and embedding information in the form of a sequence of one or more bits at each of those locations, thus representing a set of marking symbols.

Abstract: The invention relates to compounds of formula (I): wherein substituents are as defined.

Abstract: The invention relates to compounds of formula (Ic) processes for their preparation, pharmaceutical compositions containing them and to their use in medicine, particularly use in the amelioration of a clinical condition for which a Factor Xa inhibitor is indicated.

Abstract: Distributing information, including the steps of watermarking the digital content, distributing the digital content using a multi-source system, and partially fingerprinting digital content at each stage of moving information from a point of origin to the viewer. “Adaptation” of the digital content to the recipient includes maintaining the digital content in encrypted form at each such intermediate device, including decrypting the digital content with a key unique to both the device and the specific movie, selecting a portion of the watermark locations into which to embed information, embedding fingerprinting information into those locations sufficient to identify the recipient, and encrypting the fingerprinted digital content with a new such key.

Abstract: Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein W, X, Y, Z, R1, R2a, R2b, and Rx, R8 and R9 are as defined in the specification, a process for the preparation of such compounds, pharmaceutical compositions comprising such compounds and the use of such compounds in medicine.